Ontology highlight
ABSTRACT:
SUBMITTER: Ivanenkov YA
PROVIDER: S-EPMC6719509 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Ivanenkov Yan A YA Zhavoronkov Alex A Yamidanov Renat S RS Osterman Ilya A IA Sergiev Petr V PV Aladinskiy Vladimir A VA Aladinskaya Anastasia V AV Terentiev Victor A VA Veselov Mark S MS Ayginin Andrey A AA Kartsev Victor G VG Skvortsov Dmitry A DA Chemeris Alexey V AV Baimiev Alexey Kh AK Sofronova Alina A AA Malyshev Alexander S AS Filkov Gleb I GI Bezrukov Dmitry S DS Zagribelnyy Bogdan A BA Putin Evgeny O EO Puchinina Maria M MM Dontsova Olga A OA
Frontiers in pharmacology 20190827
Many pharmaceutical companies are avoiding the development of novel antibacterials due to a range of rational reasons and the high risk of failure. However, there is an urgent need for novel antibiotics especially against resistant bacterial strains. Available <i>in silico</i> models suffer from many drawbacks and, therefore, are not applicable for scoring novel molecules with high structural diversity by their antibacterial potency. Considering this, the overall aim of this study was to develop ...[more]